IXIARO
Japanese encephalitis virus, inactivated (SA14-14-2) · Japanese encephalitis
Health Canada DIN 02333279. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- IXIARO
- DIN
02333279- Vaccine
- Japanese encephalitis virus, inactivated (SA14-14-2)
- Presentation
- 6 mcg / 0.5 mL · suspension · intramuscular · 2 months and older
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| Japanese encephalitis (IXIARO) — two doses, 28 days apart Two doses 28 days apart, from 2 months of age; finished at least 1 week before travel. | 2 doses | Primary series of two doses 28 days apart. Adults 18 to 65 may use an accelerated day 0 and day 7 schedule when time is short. A booster 12 to 24 months after the primary series is recommended for continued risk. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Use if indicated for high-risk travel.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Japanese encephalitis vaccine: Canadian Immunization Guide — Chapter revised September 2023 · partial update November 2024
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365